Oxidoreductase, short chain dehydrogenase/reductase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 32 |
NetGPI | no | yes: 0, no: 33 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9AH88
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0030497 | fatty acid elongation | 6 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0008667 | 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase activity | 5 | 1 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 1 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 1 |
GO:0004312 | fatty acid synthase activity | 5 | 3 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 5 | 3 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 3 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016746 | acyltransferase activity | 3 | 3 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 244 | 250 | PF00089 | 0.279 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.383 |
CLV_NRD_NRD_1 | 369 | 371 | PF00675 | 0.558 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.286 |
CLV_PCSK_KEX2_1 | 369 | 371 | PF00082 | 0.567 |
CLV_PCSK_PC1ET2_1 | 220 | 222 | PF00082 | 0.304 |
CLV_PCSK_PC7_1 | 216 | 222 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 242 | 246 | PF00082 | 0.234 |
CLV_PCSK_SKI1_1 | 340 | 344 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.454 |
DOC_MAPK_HePTP_8 | 244 | 256 | PF00069 | 0.401 |
DOC_MAPK_MEF2A_6 | 247 | 256 | PF00069 | 0.462 |
DOC_PP4_FxxP_1 | 258 | 261 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 222 | 226 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.707 |
DOC_USP7_MATH_1 | 334 | 338 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 341 | 345 | PF00917 | 0.612 |
DOC_USP7_MATH_1 | 380 | 384 | PF00917 | 0.797 |
DOC_USP7_UBL2_3 | 495 | 499 | PF12436 | 0.380 |
DOC_WW_Pin1_4 | 177 | 182 | PF00397 | 0.592 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.541 |
DOC_WW_Pin1_4 | 406 | 411 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 418 | 423 | PF00397 | 0.567 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.704 |
LIG_14-3-3_CanoR_1 | 349 | 353 | PF00244 | 0.740 |
LIG_14-3-3_CanoR_1 | 402 | 410 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 48 | 57 | PF00244 | 0.659 |
LIG_14-3-3_CanoR_1 | 64 | 69 | PF00244 | 0.722 |
LIG_14-3-3_CanoR_1 | 79 | 83 | PF00244 | 0.633 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.581 |
LIG_BIR_III_1 | 1 | 5 | PF00653 | 0.579 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.579 |
LIG_BRCT_BRCA1_1 | 419 | 423 | PF00533 | 0.641 |
LIG_CSL_BTD_1 | 304 | 307 | PF09270 | 0.558 |
LIG_eIF4E_1 | 431 | 437 | PF01652 | 0.293 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.603 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.481 |
LIG_FHA_1 | 263 | 269 | PF00498 | 0.473 |
LIG_FHA_1 | 392 | 398 | PF00498 | 0.703 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.603 |
LIG_FHA_2 | 438 | 444 | PF00498 | 0.330 |
LIG_HCF-1_HBM_1 | 72 | 75 | PF13415 | 0.625 |
LIG_LIR_Apic_2 | 337 | 341 | PF02991 | 0.666 |
LIG_LIR_Gen_1 | 210 | 218 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 424 | 435 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 81 | 90 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 210 | 215 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 311 | 316 | PF02991 | 0.586 |
LIG_LIR_Nem_3 | 424 | 430 | PF02991 | 0.364 |
LIG_Pex14_2 | 423 | 427 | PF04695 | 0.457 |
LIG_Pex14_2 | 59 | 63 | PF04695 | 0.580 |
LIG_PTAP_UEV_1 | 4 | 9 | PF05743 | 0.583 |
LIG_PTB_Apo_2 | 456 | 463 | PF02174 | 0.315 |
LIG_PTB_Phospho_1 | 456 | 462 | PF10480 | 0.316 |
LIG_RPA_C_Fungi | 125 | 137 | PF08784 | 0.498 |
LIG_SH2_GRB2like | 463 | 466 | PF00017 | 0.363 |
LIG_SH2_PTP2 | 434 | 437 | PF00017 | 0.483 |
LIG_SH2_SRC | 432 | 435 | PF00017 | 0.240 |
LIG_SH2_SRC | 468 | 471 | PF00017 | 0.485 |
LIG_SH2_STAP1 | 373 | 377 | PF00017 | 0.720 |
LIG_SH2_STAT5 | 102 | 105 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.220 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 281 | 284 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 429 | 432 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 434 | 437 | PF00017 | 0.273 |
LIG_SH3_1 | 54 | 60 | PF00018 | 0.538 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.445 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.482 |
LIG_SH3_3 | 301 | 307 | PF00018 | 0.494 |
LIG_SH3_3 | 54 | 60 | PF00018 | 0.538 |
LIG_SUMO_SIM_anti_2 | 172 | 177 | PF11976 | 0.386 |
LIG_SUMO_SIM_anti_2 | 228 | 233 | PF11976 | 0.348 |
LIG_TYR_ITIM | 430 | 435 | PF00017 | 0.342 |
MOD_CDK_SPK_2 | 303 | 308 | PF00069 | 0.443 |
MOD_CDK_SPK_2 | 43 | 48 | PF00069 | 0.678 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.584 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.469 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.725 |
MOD_CK1_1 | 344 | 350 | PF00069 | 0.570 |
MOD_CK1_1 | 368 | 374 | PF00069 | 0.660 |
MOD_CK1_1 | 383 | 389 | PF00069 | 0.725 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.629 |
MOD_CK2_1 | 383 | 389 | PF00069 | 0.497 |
MOD_CK2_1 | 437 | 443 | PF00069 | 0.401 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.656 |
MOD_Cter_Amidation | 134 | 137 | PF01082 | 0.523 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.477 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.621 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.339 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.617 |
MOD_GlcNHglycan | 284 | 287 | PF01048 | 0.239 |
MOD_GlcNHglycan | 299 | 302 | PF01048 | 0.505 |
MOD_GlcNHglycan | 370 | 373 | PF01048 | 0.684 |
MOD_GlcNHglycan | 385 | 388 | PF01048 | 0.635 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.609 |
MOD_GlcNHglycan | 423 | 426 | PF01048 | 0.401 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.688 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.588 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.446 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.564 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.534 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.310 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.660 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.649 |
MOD_GSK3_1 | 39 | 46 | PF00069 | 0.511 |
MOD_GSK3_1 | 417 | 424 | PF00069 | 0.460 |
MOD_N-GLC_1 | 225 | 230 | PF02516 | 0.494 |
MOD_N-GLC_2 | 138 | 140 | PF02516 | 0.340 |
MOD_N-GLC_2 | 450 | 452 | PF02516 | 0.333 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.418 |
MOD_NEK2_1 | 417 | 422 | PF00069 | 0.456 |
MOD_NEK2_1 | 423 | 428 | PF00069 | 0.327 |
MOD_NEK2_1 | 473 | 478 | PF00069 | 0.572 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.511 |
MOD_PIKK_1 | 380 | 386 | PF00454 | 0.735 |
MOD_PIKK_1 | 442 | 448 | PF00454 | 0.320 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.480 |
MOD_PKA_2 | 222 | 228 | PF00069 | 0.386 |
MOD_PKA_2 | 348 | 354 | PF00069 | 0.681 |
MOD_PKA_2 | 368 | 374 | PF00069 | 0.700 |
MOD_PKA_2 | 401 | 407 | PF00069 | 0.391 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.537 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.447 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.332 |
MOD_Plk_1 | 225 | 231 | PF00069 | 0.462 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.438 |
MOD_Plk_4 | 423 | 429 | PF00069 | 0.402 |
MOD_Plk_4 | 444 | 450 | PF00069 | 0.330 |
MOD_Plk_4 | 485 | 491 | PF00069 | 0.289 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.649 |
MOD_ProDKin_1 | 177 | 183 | PF00069 | 0.487 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.420 |
MOD_ProDKin_1 | 406 | 412 | PF00069 | 0.417 |
MOD_ProDKin_1 | 418 | 424 | PF00069 | 0.450 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.643 |
MOD_SUMO_for_1 | 498 | 501 | PF00179 | 0.486 |
TRG_ENDOCYTIC_2 | 432 | 435 | PF00928 | 0.366 |
TRG_ER_diArg_1 | 136 | 139 | PF00400 | 0.400 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2S7 | Leptomonas seymouri | 33% | 97% |
A0A0N1HZ81 | Leptomonas seymouri | 69% | 90% |
A0A0S4IWT0 | Bodo saltans | 32% | 100% |
A0A0S4IZG2 | Bodo saltans | 35% | 100% |
A0A0S4J1I6 | Bodo saltans | 43% | 100% |
A0A1X0NVT8 | Trypanosomatidae | 36% | 100% |
A0A1X0NVV6 | Trypanosomatidae | 51% | 97% |
A0A3Q8ID46 | Leishmania donovani | 34% | 99% |
A0A3Q8IM89 | Leishmania donovani | 29% | 100% |
A0A3R7K071 | Trypanosoma rangeli | 51% | 100% |
A0A3R7N7S2 | Trypanosoma rangeli | 26% | 100% |
A0A3S5H7D5 | Leishmania donovani | 99% | 100% |
A0A3S7X986 | Leishmania donovani | 24% | 100% |
A0A422N2B6 | Trypanosoma rangeli | 34% | 100% |
A4HDP2 | Leishmania braziliensis | 86% | 100% |
A4HDP3 | Leishmania braziliensis | 32% | 98% |
A4HMN7 | Leishmania braziliensis | 27% | 100% |
C9ZWC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
C9ZWC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
C9ZZF1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AF41 | Leishmania major | 22% | 100% |
E9AH89 | Leishmania infantum | 33% | 99% |
E9AHV6 | Leishmania infantum | 29% | 100% |
E9AHV8 | Leishmania infantum | 24% | 100% |
E9AX26 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9AX27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9B694 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B696 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
Q4QAE9 | Leishmania major | 34% | 100% |
Q4QAF0 | Leishmania major | 93% | 100% |
V5BAF4 | Trypanosoma cruzi | 34% | 100% |
V5BNY6 | Trypanosoma cruzi | 28% | 100% |